Moderna reported that its vaccine was 50% effective at preventing lower respiratory disease following RSV infection, falling short of numbers reported by GSK and Pfizer …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
The US biosimilar market has always been distinct from the EU market, particularly when it comes to the designation of certain biosimilars as being interchangeable
A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) evaluated the use of tirzepatide in overweight/obese adults with type 1 diabetes.
Moderna’s manufacturing future in Africa is less clear after the company held back plans to build an mRNA vaccine production site in Kenya. “Moderna has